Skip to main navigation
Skip Navigation
Landos Biopharma
  • - Landos - Corp Menu

  • About Us
    • Our Company
      • Management Team
      • Board of Directors
      • Clinical Advisory Board
    • Contact Us
  • Product Candidates
    • Our Pipeline
    • Preclinical Candidates
    • Clinical Trials
  • Science
    • LANCE Precision Medicine Platform
    • Immunometabolic Pathways
    • Publications
  • Investors/Media
    • Investor/Media Home
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investors/Media FAQs
  • Careers
    • Why Landos?
    • Open Positions
Identifying novel pathways at the interface of immunity and metabolism

SEC Filing Details

Document Details

Form
CORRESP
Filing Date
Feb 1, 2021
Document Date
Feb 1, 2021
Form Description
CORRESP
Filing Group
Other
Company
Landos Biopharma
Issuer
Landos Biopharma, Inc.

Filing Formats

View HTML
Download PDF 77.1 KB
Download DOC
Download XLS

Investors/Media

Investor Relations

  • Investor/Media Home
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investors/Media FAQs

- Landos - Investor Tools

  • Print Page
  • RSS Feeds
  • Email Alerts

Contact

Landos Biopharma, Inc.
1800 Kraft Drive, Suite 216
Blacksburg, VA 24060
info@landosbiopharma.com
(540) 218-2232

- Landos - Footer Menu

  • Site Map
  • Terms of Use
  • Privacy Policy

©2022 Landos Biopharma All Rights Reserved.